According to information from Hongri Pharmaceutical, recently, the active ingredient protein iron succinate from Huzhou Zhanwang Pharmaceutical Co., Ltd., a subsidiary of Hongri Pharmaceutical, passed a related review by the Drug Evaluation Center of the State Drug Administration. The registration status was changed from “I” to “A”. This approval has further enhanced the company's market competitiveness.

According to information from Hongri Pharmaceutical, recently, the active ingredient protein iron succinate from Huzhou Zhanwang Pharmaceutical Co., Ltd., a subsidiary of Hongri Pharmaceutical, passed a related review by the Drug Evaluation Center of the State Drug Administration. The registration status was changed from “I” to “A”. This approval has further enhanced the company's market competitiveness.